{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:38:10Z","timestamp":1778539090468,"version":"3.51.4"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T00:00:00Z","timestamp":1678320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Partnership for Vivax Elimination"},{"DOI":"10.13039\/501100004167","name":"Medicines for Malaria Venture","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004167","id-type":"DOI","asserted-by":"publisher"}]},{"name":"APMEN"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Recent advances in G6PD deficiency screening and treatment are rapidly changing the landscape of radical cure of vivax malaria available for National Malaria Programs (NMPs). While NMPs await the WHO\u2019s global policy guidance on these advances, they will also need to consider different contextual factors related to the vivax burden, health system capacity, and resources available to support changes to their policies and practices. Therefore, we aim to develop an Options Assessment Toolkit (OAT) that enables NMPs to systematically determine optimal radical cure options for their given environments and potentially reduce decision-making delays. This protocol outlines the OAT development process.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Utilizing participatory research methods, the OAT will be developed in four phases where the NMPs and experts will have active roles in designing the research process and the toolkit. In the first phase, an essential list of epidemiological, health system, and political &amp; economic factors will be identified. In the second phase, 2\u20133 NMPs will be consulted to determine the relative priority and measurability of these factors. These factors and their threshold criteria will be validated with experts using a modified e-Delphi approach. In addition, 4\u20135 scenarios representing country contexts in the Asia Pacific region will be developed to obtain the expert-recommended radical cure options for each scenario. In the third phase, additional components of OAT, such as policy evaluation criteria, latest information on new radical cure options, and others, will be finalized. The OAT will be pilot-tested with other Asia Pacific NMPs in the final phase.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Human Research Ethics Committee approval has been received from the Northern Territory, Department of Health, and Menzies School of Health Research (HREC Reference Number: 2022\u20134245). The OAT will be made available for the NMPs, introduced at the APMEN Vivax Working Group annual meeting, and reported in international journals.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0280950","type":"journal-article","created":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T13:52:20Z","timestamp":1678369940000},"page":"e0280950","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Study protocol for development of an options assessment toolkit (OAT) for national malaria programs in Asia Pacific to determine best combinations of vivax radical cure for their given contexts"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5110-3742","authenticated-orcid":true,"given":"Manash","family":"Shrestha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josselyn","family":"Neukom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjaya","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5726-562X","authenticated-orcid":true,"given":"Muhammad Naeem","family":"Habib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9369-8887","authenticated-orcid":true,"given":"Lyndes","family":"Wini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tran Thanh","family":"Duong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ngo Duc","family":"Thang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karma","family":"Lhazeen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamala","family":"Thriemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline Anita","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2023,3,9]]},"reference":[{"issue":"6","key":"pone.0280950.ref001","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.pt.2020.03.009","article-title":"Plasmodium vivax in the era of the shrinking P. falciparum map","volume":"36","author":"RN Price","year":"2020","journal-title":"Trends Parasitol"},{"issue":"3","key":"pone.0280950.ref002","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.4269\/ajtmh.20-0186","article-title":"Estimating the proportion of Plasmodium vivax recurrences caused by relapse: a systematic review and meta-analysis","volume":"103","author":"RJ Commons","year":"2020","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"pone.0280950.ref003","doi-asserted-by":"crossref","first-page":"e0004582","DOI":"10.1371\/journal.pntd.0004582","article-title":"The incidence and differential seasonal patterns of Plasmodium vivax primary infections and relapses in a cohort of children in Papua New Guinea.","volume":"10","author":"A Ross","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"pone.0280950.ref004","volume-title":"WHO guideline for malaria, 13 July 2021","author":"World Health Organization","year":"2021"},{"issue":"5","key":"pone.0280950.ref005","doi-asserted-by":"crossref","first-page":"e1002299","DOI":"10.1371\/journal.pmed.1002299","article-title":"Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: a randomized controlled trial.","volume":"14","author":"T Abreha","year":"2017","journal-title":"PLoS Med"},{"issue":"8","key":"pone.0280950.ref006","doi-asserted-by":"crossref","first-page":"e1002379","DOI":"10.1371\/journal.pmed.1002379","article-title":"Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: a hospital-based cohort study.","volume":"14","author":"NM Douglas","year":"2017","journal-title":"PLoS Med"},{"issue":"10202","key":"pone.0280950.ref007","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(19)31285-1","article-title":"Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial","volume":"394","author":"WRJ Taylor","year":"2019","journal-title":"Lancet"},{"issue":"3","key":"pone.0280950.ref008","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa1710775","article-title":"Single-dose tafenoquine to prevent relapse of plasmodium vivax malaria.","volume":"380","author":"MVG Lacerda","year":"2019","journal-title":"N Eng J Med"},{"issue":"3","key":"pone.0280950.ref009","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa1802537","article-title":"Tafenoquine versus primaquine to prevent relapse of Plasmodium vivax malaria.","volume":"380","author":"A Llanos-Cuentas","year":"2019","journal-title":"N Eng J Med"},{"issue":"11","key":"pone.0280950.ref010","doi-asserted-by":"crossref","first-page":"e0206331","DOI":"10.1371\/journal.pone.0206331","article-title":"Field evaluation of quantitative point of care diagnostics to measure glucose-6-phosphate dehydrogenase activity.","volume":"13","author":"MS Alam","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"pone.0280950.ref011","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4269\/ajtmh.18-0612","article-title":"Evaluation of a novel quantitative test for glucose-6-phosphate dehydrogenase deficiency: bringing quantitative testing for glucose-6-phosphate dehydrogenase deficiency closer to the patient","volume":"100","author":"S Pal","year":"2018","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"pone.0280950.ref012","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1186\/s12936-021-03959-w","article-title":"Opening the policy blackbox: unravelling the process for changing national diagnostic and treatment guidelines for vivax malaria in seven countries.","volume":"20","author":"V Ruwanpura","year":"2021","journal-title":"Malar J."},{"issue":"6","key":"pone.0280950.ref013","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1080\/09540121.2011.630366","article-title":"Decision maker priorities for providing antiretroviral therapy in HIV-infected South Africans: a qualitative assessment","volume":"24","author":"AD Kimmel","year":"2012","journal-title":"AIDS Care"},{"key":"pone.0280950.ref014","unstructured":"Shrestha M. The last kilometre\u2013what are stakeholders\u2019 priorities to achieve vivax elimination by 2030? 8th International conference on Plasmodium vivax research 2022. Online, 2022."},{"issue":"1","key":"pone.0280950.ref015","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12961-020-00554-4","article-title":"Development of the WHO antenatal care recommendations adaptation toolkit: a standardised approach for countries","volume":"18","author":"M Barreix","year":"2020","journal-title":"Health Res Policy Syst"},{"issue":"1","key":"pone.0280950.ref016","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12911-014-0121-7","article-title":"Scoping review of toolkits as a knowledge translation strategy in health.","volume":"14","author":"R Barac","year":"2014","journal-title":"BMC Med Inform Decis Mak"},{"issue":"1","key":"pone.0280950.ref017","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13012-019-0929-8","article-title":"Spread tools: a systematic review of components, uptake, and effectiveness of quality improvement toolkits.","volume":"14","author":"O Hempel S","year":"2019","journal-title":"Implement Sci."},{"issue":"1","key":"pone.0280950.ref018","doi-asserted-by":"crossref","first-page":"13244","DOI":"10.35844\/001c.13244","article-title":"Participatory research methods\u2013choice points in the research process.","volume":"1","author":"LM Vaughn","year":"2020","journal-title":"J Particip Res Methods"},{"key":"pone.0280950.ref019","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-93191-3","author":"T Abma","year":"2019","journal-title":"Participatory research for health and social well-being: Springer"},{"issue":"4","key":"pone.0280950.ref020","doi-asserted-by":"crossref","first-page":"e006808","DOI":"10.1136\/bmjopen-2014-006808","article-title":"The effectiveness of toolkits as knowledge translation strategies for integrating evidence into clinical care: a systematic review","volume":"5","author":"J Yamada","year":"2015","journal-title":"BMJ Open"},{"issue":"1","key":"pone.0280950.ref021","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/1471-2288-11-174","article-title":"Conducting online expert panels: a feasibility and experimental replicability study.","volume":"11","author":"D Khodyakov","year":"2011","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"pone.0280950.ref022","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.acap.2019.07.012","article-title":"Using the modified delphi method to develop a tool to assess pediatric residents supervising on inpatient rounds.","volume":"20","author":"KA Miller","year":"2020","journal-title":"Acad Pediatr"},{"issue":"12","key":"pone.0280950.ref023","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1038\/s41366-018-0313-9","article-title":"A Delphi study to build consensus on the definition and use of big data in obesity research","volume":"43","author":"C Vogel","year":"2019","journal-title":"Int J Obes (Lond)."},{"issue":"6","key":"pone.0280950.ref024","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups.","volume":"19","author":"A Tong","year":"2007","journal-title":"Int J Qual Health Care"},{"issue":"3","key":"pone.0280950.ref025","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/puar.12475","article-title":"Toward more \u201cevidence\u2010informed\u201d policy making?.","volume":"76","author":"BW Head","year":"2016","journal-title":"Public Admin Rev"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0280950","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T13:52:51Z","timestamp":1678369971000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0280950"}},"subtitle":[],"editor":[{"given":"Richard","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,3,9]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0280950","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.07.22.22277913","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,9]]}}}